While the format for the 10th Annual Society for Laboratory Automation and Screening (SLAS) is different for 2021, the program will include the same high-quality scientific discovery, technology and innovation research attendees have come to expect over the last decade.

SLAS2021 Digital will feature more than 80 scientific talks from 10 educational tracks and 45 vendor tutorials to ignite virtual discussions and brainstorming. SLAS2021 Digital will also feature keynote speakers Deborah Slipetz, Ph.D., (Merck) and Atul Butte, M.D., Ph.D., (University of California Health System), both of whom will deliver impactful and relevant presentations on topics sure to get you excited about the future of drug discovery and automation technology.

Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities. With nearly 40 years of publishing experience, GEN maintains unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry.

ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.

Check out this virtual event at Society for Laboratory Automation and Screening (SLAS)